instrument_fundamentals
date | Close | change | Change (%) | instr__open | High | Low |
---|
instr__news

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - February 20, 2025 - Zacks.com

Novavax (NVAX) Declines More Than Market: Some Information for Investors - February 20, 2025 - Zacks.com

Novavax, Inc. (NASDAQ:NVAX) Given Average Recommendation of "Hold" by Brokerages

Novavax (NVAX) to Release Quarterly Earnings on Wednesday

Novavax to Report Q4 Earnings: Here's What You Can Expect - February 19, 2025 - Zacks.com

Novavax, Inc. (NASDAQ:NVAX) Receives $17.83 Consensus PT from Brokerages

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Brokerages

Novavax (NVAX) Outperforms Broader Market: What You Need to Know - February 10, 2025 - Zacks.com

Novavax (NVAX) Rises But Trails Market: What Investors Should Know - February 4, 2025 - Zacks.com

Novavax (NASDAQ:NVAX) Stock Price Down 5.7% - Should You Sell?

FY2025 EPS Estimates for Novavax Increased by Zacks Research

Zacks Research Has Positive Estimate for Novavax Q2 Earnings

Novavax (NASDAQ:NVAX) Shares Down 5.7% - Here's Why

Novavax, Inc. (NASDAQ:NVAX) is Shah Capital Management's 2nd Largest Position

Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know - January 27, 2025 - Zacks.com

Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Analysts

Updated Novavax COVID-19 vaccine available at some GP clinics until Apr 30